Skip to main content

Integer Holdings Corporation (ITGR) Stock Analysis

Range Bound setup

SellModerate Confidence

Healthcare · Medical Devices

Sell if holding. Analyst target reached at $85.63 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak overall score: 4.4/10.

Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets under the Greatbatch Medical and Lake Region Medical brands. It sells components, subassemblies, and finished devices primarily to large... Read more

$85.63+4.0% A.UpsideScore 4.4/10#39 of 40 Medical Devices
Stop $79.81Target $89.25(resistance)A.R:R -0.5:1
Analyst target$93.25+8.9%8 analysts
$89.25our TP
$85.63price
$93.25mean
$101

Sell if holding. Analyst target reached at $85.63 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak overall score: 4.4/10. Chart setup: RSI 45 mid-range, Bollinger mid-band. Score 4.4/10, moderate confidence.

Passes 4/7 gates (clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (3/4)
Risks
Analyst target reached - limited upside remaining
Weak overall score: 4.4/10
Weak growth

Key Metrics

P/E (TTM)22.0
P/E (Fwd)12.4
Mkt Cap$3.0B
EV/EBITDA12.2
Profit Mgn7.6%
ROE8.6%
Rev Growth0.5%
Beta
DividendNone
Rating analysts17

Quality Signals

Piotroski F6/9

Options Flow

P/C7.23bearish
IV66%elevated
Max Pain$70-18.3% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomertop three customers49%
    10-K Item 1A: 'In 2025, our top three customers collectively accounted for approximately 49% of our revenues.'

Material Events(8-K, last 90d)

  • 2026-03-12Item 5.02LOW
    Board to add James F. Flanagan and investor-designated Aaron Kapito per Cooperation Agreement with Irenic Capital signed March 9, 2026. Two incumbent directors will not stand for re-election at 2026 Annual Meeting. Board composition change, no officer departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
2.6
Low model confidence on this dimension (33%).

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.0
Quality Rank
4.7
Value Rank
6.5

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.7
Ma Position
1.0
Volume
1.0
Rsi
4.5
Obv
10.0
Volume accumulation (rising OBV)Below 200-MA, MA slope -5.3%/30d — confirmed downtrend
GatesMomentum 3.4<4.5A.R:R -0.5=NEGATIVEDeath cross (50MA < 200MA)Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
45 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $77.05Resistance $91.07

Price Targets

$80
$89
A.Upside+4.2%
A.R:R-0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-5.5% upside)
! Momentum score 3.4/10 — below 4.5 minimum
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-04-30 (nulld)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ITGR stock a buy right now?

Sell if holding. Analyst target reached at $85.63 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak overall score: 4.4/10. Chart setup: RSI 45 mid-range, Bollinger mid-band. Prior stop was $79.81. Score 4.4/10, moderate confidence.

What is the ITGR stock price target?

Take-profit target: $89.25 (+4.0% upside). Prior stop was $79.81. Stop-loss: $79.81.

What are the risks of investing in ITGR?

Analyst target reached - limited upside remaining; Weak overall score: 4.4/10; Weak growth.

Is ITGR overvalued or undervalued?

Integer Holdings Corporation trades at a P/E of 22.0 (forward 12.4). TrendMatrix value score: 6.3/10. Verdict: Sell.

What do analysts say about ITGR?

17 analysts cover ITGR with a consensus score of 3.7/5. Average price target: $93.

What does Integer Holdings Corporation do?Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm...

Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets under the Greatbatch Medical and Lake Region Medical brands. It sells components, subassemblies, and finished devices primarily to large multinational OEM customers.

Related stocks: GMED (Globus Medical, Inc.) · TMDX (TransMedics Group, Inc.) · DXCM (DexCom, Inc.) · INSP (Inspire Medical Systems, Inc.) · HAE (Haemonetics Corporation)